Association of disease progression on ibrutinib therapy with the acquisition of resistance mutations: A single-center experience of 267 patients.
Jennifer Ann Woyach
Consultant or Advisory Role - Pharmacyclics (U)
Amy S. Ruppert
No relevant relationships to disclose
Gerard Lozanski
No relevant relationships to disclose
Arletta Lozanski
No relevant relationships to disclose
Nyla A. Heerema
Research Funding - Pharmacyclics
Weiqiang Zhao
No relevant relationships to disclose
Lynne Abruzzo
No relevant relationships to disclose
Amber Gordon
No relevant relationships to disclose
Jeffrey Alan Jones
Consultant or Advisory Role - Janssen; Pharmacyclics
Research Funding - Pharmacyclics
Joseph M. Flynn
No relevant relationships to disclose
Samantha Mary Jaglowski
Research Funding - Pharmacyclics
Leslie A. Andritsos
No relevant relationships to disclose
Farrukh Awan
No relevant relationships to disclose
Kristie A. Blum
No relevant relationships to disclose
Michael R. Grever
No relevant relationships to disclose
Amy J. Johnson
No relevant relationships to disclose
John C. Byrd
Research Funding - Pharmacyclics
Kami J. Maddocks
Research Funding - Pharmacyclics